View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 4, 2014

Baxter to develop new hospital admixing facility in Canada

Baxter has unveiled plans to construct a new facility in Mississauga, Ontario, Canada, for the centralised intravenous admixing pharmacy service (CIVA).

Baxter

Baxter has unveiled plans to construct a new facility in Mississauga, Ontario, Canada, for the centralised intravenous admixing pharmacy service (CIVA).

The new CIVA pharmacy service, involving an investment of $10m, is said to support the Canadian hospitals, clinics and other care facilities by providing ready-to-administer intravenous (IV) admixtures, including chemotherapy, high alert medications and anti-infectives.

Baxter president Mike Oliver said: "Pharmacy practice is a dynamic environment and since its inception Baxter CIVA worked closely with healthcare partners to develop innovative solutions.

"The new CIVA facility will triple its current size, helping to accommodate increasing and evolving customer needs for ready-to-administer medications and sharing best practices in IV admixing."

"The new CIVA pharmacy service, involving an investment of $10m, is said to support the Canadian hospitals, clinics and other care facilities by providing ready-to-administer intravenous (IV) admixtures."

CIVA will also include a new training facility, under which Baxter will collaborate with professional organisations, academia, and hospital pharmacists and technicians to support their certification requirements, as well as to improve skillset in IV admixing.

The CIVA will support hospital pharmacies to increase the IV admixing capacity of their in-house pharmacy without additional capital investment, said Baxter.

Ontario ministry of economic development, employment and infrastructure minister Brad Duguid said: "Baxter has been a long-standing healthcare leader and innovation partner in Ontario, and our growing life sciences ecosystem and innovation agenda has greatly benefited from their leadership to date."

Baxter’s new facility is expected to commence operations in October 2015.

In Canada, Baxter opened the first outsourced hospital admixing service in 1986, in partnership with Toronto General Hospital.


Image: Baxter CIVA supports Canadian hospitals with ready-to-administer intravenous admixtures including chemotherapy, high alert medications and anti-infectives. Photo: courtesy of CNW Group/Baxter Corporation.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management